Testosterone Cypionate Cost in Iowa (2026): Cash, Insurance, and Compounded Pricing

How Much Does Testosterone Cypionate Cost in Iowa in 2026?
At a glance
- Average Iowa cash price / $60 per month (generic, 200 mg/mL vial)
- Manufacturer list price / approximately $100 per month
- Compounded 503A price / around $80 per month
- Iowa Medicaid coverage / not covered for male hypogonadism
- Telehealth prescribing / legal and available statewide in Iowa
- Typical dosing schedule / once or twice weekly, intramuscular or subcutaneous
- Prescription status / Schedule III controlled substance, prescription only
- Discount card savings / may reduce retail cost by 30 to 60 percent
Iowa Cash-Pay Pricing for Testosterone Cypionate
The average cash price for generic testosterone cypionate at Iowa retail pharmacies is roughly $60 per month in 2026, based on a standard 200 mg/mL, 1 mL vial. That figure reflects the actual counter price, not the manufacturer list price of approximately $100 per month that appears on wholesale schedules.
Pricing varies by pharmacy. Hy-Vee, Walgreens, and CVS locations across Des Moines, Cedar Rapids, and Iowa City may differ by $15 to $25 for the same generic vial. Independent pharmacies sometimes match or beat chain pricing, particularly in smaller markets like Dubuque or Sioux City. Pharmacy discount aggregators (GoodRx, RxSaver, SingleCare) routinely display Iowa-specific coupons that pull the cash price into the $30 to $50 range for a one-month supply 1.
Brand-name Depo-Testosterone costs significantly more. Expect $150 to $250 per month without insurance. Because generic testosterone cypionate is therapeutically equivalent and rated AB by the FDA, most prescribers in Iowa default to the generic 2.
One practical point: multi-dose 10 mL vials cost less per milligram than single-dose 1 mL vials. If your prescribed dose allows it, asking your pharmacist about the 10 mL option can cut monthly costs by 40 percent or more.
Iowa Medicaid and Testosterone Cypionate Coverage
Iowa Medicaid does not cover testosterone cypionate for the diagnosis of male hypogonadism as of 2026. This applies to both fee-for-service Medicaid and the state's managed care organizations (Iowa Total Care and Amerigroup Iowa).
The exclusion is not unique to Iowa. Many state Medicaid programs classify testosterone replacement therapy (TRT) as non-preferred or excluded for hypogonadism, requiring prior authorization that is frequently denied. Iowa's formulary lists testosterone cypionate under a carve-out that limits reimbursement to specific endocrine conditions in transgender care, where coverage may apply under different diagnostic codes 3.
For Iowa Medicaid enrollees who need TRT for confirmed hypogonadism (two morning total testosterone levels below 300 ng/dL per Endocrine Society 2018 guidelines), realistic options include:
- Paying the $60 per month cash price out of pocket
- Using a 503A compounding pharmacy
- Applying manufacturer or pharmacy discount programs
- Appealing the Medicaid denial with supporting lab work and specialist documentation
Appeals succeed occasionally. But the process takes 30 to 90 days and requires documentation showing medical necessity, failed alternative therapies, and supporting endocrinology notes.
Compounded Testosterone Cypionate in Iowa: Legal and Available
Compounded testosterone cypionate is legal in Iowa through 503A pharmacies. These are state-licensed compounding pharmacies that prepare medications pursuant to individual patient prescriptions, regulated under Iowa Board of Pharmacy rules and federal law (Section 503A of the FD&C Act).
The average price for compounded testosterone cypionate in Iowa is approximately $80 per month. That number may seem higher than the $60 retail generic average, but compounded formulations offer flexibility that commercial products do not. Custom concentrations (e.g., 250 mg/mL instead of the standard 200 mg/mL), alternative carrier oils (grapeseed or sesame instead of cottonseed), and preservative-free options are all possible through compounding 4.
Iowa has approximately 30 to 40 pharmacies with active 503A compounding licenses. Bellevue, Iowa City, and West Des Moines each have multiple options. Patients with cottonseed oil allergies or those who require subcutaneous-specific concentrations frequently turn to compounding as a medical necessity rather than a cost play.
A critical distinction: 503A compounded testosterone is not the same as products from 503B outsourcing facilities, which produce larger batches without individual prescriptions. The FDA has increased scrutiny of 503B facilities since 2023, and several have received warning letters for sterility failures. Iowa patients should confirm their pharmacy holds a current 503A license through the Iowa Board of Pharmacy verification portal.
Insurance Coverage Beyond Medicaid
Private insurance plans in Iowa generally cover testosterone cypionate for diagnosed hypogonadism, though coverage quality varies by carrier and plan tier.
Most Iowa Blue Cross Blue Shield, Wellmark, and UnitedHealthcare plans include generic testosterone cypionate on their formulary, typically at Tier 2 (preferred generic) or Tier 3 (non-preferred generic). Copays range from $10 to $45 per month depending on the plan. Prior authorization is the standard gatekeeper. Insurers require two documented morning total testosterone levels below 300 ng/dL, drawn between 7:00 and 10:00 AM, plus documented symptoms of hypogonadism 5.
The T-Trials (Testosterone Trials), a coordinated set of seven placebo-controlled studies published in the New England Journal of Medicine (N=790 men aged 65 and older), demonstrated that testosterone treatment improved sexual function, physical activity, and mood over 12 months 6. These findings form the evidence base that most Iowa insurers reference when adjudicating TRT prior authorization requests.
For employer-sponsored plans, coverage depends on the pharmacy benefit manager (PBM). Express Scripts and CVS Caremark, the two largest PBMs operating in Iowa, both include generic testosterone cypionate but may require step therapy (trying topical testosterone gel first) before approving injectables.
Self-funded employer plans have the widest variation. Some cover TRT with no prior authorization. Others exclude it entirely. Ask your HR department for the Summary of Benefits and Coverage (SBC) document, which lists formulary exclusions explicitly.
Telehealth TRT Prescribing in Iowa
Iowa permits telehealth prescribing of testosterone cypionate. The state adopted permanent telehealth parity legislation in 2021, and the Iowa Board of Medicine allows controlled substance prescribing via telemedicine when a valid provider-patient relationship exists.
This means Iowa residents can obtain testosterone cypionate prescriptions from licensed telehealth platforms without an in-person visit, provided the prescriber holds an active Iowa medical license or practices under an interstate compact agreement. The Ryan Haight Act still requires that the prescribing provider conduct at least one real-time audio-visual evaluation before writing a Schedule III prescription 7.
Telehealth TRT consultations in Iowa typically cost $99 to $199 for the initial visit and $49 to $99 for follow-ups. Lab work (total testosterone, free testosterone, CBC, metabolic panel, PSA for men over 40) is ordered through Quest Diagnostics or Labcorp draw sites. Iowa has Quest locations in Des Moines, Cedar Rapids, Davenport, Waterloo, Iowa City, and Ames. Labcorp coverage is thinner but growing.
The total first-month cost through telehealth, including consultation, labs, and medication, runs $200 to $350. Months two through twelve drop to $60 to $100 for medication only, plus periodic lab monitoring every 3 to 6 months.
How to Find the Cheapest Testosterone Cypionate in Iowa
Price optimization in Iowa follows a clear hierarchy. Start at the top and work down.
Step 1: Check insurance formulary status. If your plan covers generic testosterone cypionate at Tier 2, your copay may be $10 to $25. That beats every other option.
Step 2: Use pharmacy discount cards. GoodRx, RxSaver, and SingleCare coupons for testosterone cypionate 200 mg/mL (1 mL) at Iowa pharmacies currently show prices between $28 and $55. These work at Hy-Vee, Walgreens, CVS, and Walmart pharmacies statewide. Discount cards cannot be combined with insurance.
Step 3: Request a multi-dose vial. A 10 mL vial of testosterone cypionate 200 mg/mL contains roughly 8 to 10 weeks of medication at a standard 100 mg/week dose. The per-month cost drops to $25 to $40 in many cases.
Step 4: Consider 503A compounding. At $80 per month, compounding is not the cheapest route for most patients. But if you need a non-standard concentration, alternative oil base, or preservative-free preparation, the premium is modest.
Step 5: Explore manufacturer savings cards. Some generic manufacturers offer co-pay assistance cards that reduce out-of-pocket costs by $20 to $50 per fill. These cards change frequently. Ask your pharmacist which manufacturer they stock and whether a current card is available.
A 2020 analysis in the Journal of Urology found that testosterone cypionate injection was the most cost-effective TRT formulation across all delivery methods, with annual costs 60 to 80 percent lower than transdermal gels and patches 8.
Clinical Considerations for Iowa TRT Patients
Cost matters, but clinical monitoring determines whether TRT is safe and effective over time. The Endocrine Society recommends checking hematocrit levels 3 to 6 months after starting testosterone cypionate, then annually 5. Testosterone cypionate raises hematocrit in approximately 20 percent of men, and levels above 54 percent require dose reduction or temporary discontinuation to reduce thromboembolic risk.
PSA screening for men over 40 should occur at baseline and at 3 to 6 months. The 2010 Endocrine Society guideline recommends against starting TRT in men with a PSA above 4 ng/mL without urological evaluation 9.
Iowa has 14 board-certified endocrinologists (per the American Board of Internal Medicine 2025 directory), concentrated in Des Moines, Iowa City, and Cedar Rapids. Wait times for new endocrinology patients average 6 to 12 weeks. Primary care physicians and telehealth providers prescribe the majority of TRT in the state, making familiarity with monitoring protocols especially important.
Standard dosing for testosterone cypionate in hypogonadal men is 100 to 200 mg every 7 to 14 days via intramuscular injection, or 50 to 100 mg twice weekly via subcutaneous injection for more stable serum levels. The twice-weekly subcutaneous protocol has gained traction because it reduces peak-trough fluctuations and may lower hematocrit elevation risk compared to biweekly intramuscular dosing 10.
Iowa-Specific Regulatory Notes
Testosterone cypionate is a Schedule III controlled substance under both federal and Iowa law (Iowa Code Chapter 124). Iowa pharmacies must report all Schedule III dispensing to the Iowa Prescription Monitoring Program (PMP). Prescribers are required to check the PMP before writing a testosterone prescription.
Iowa does not impose state-level restrictions on testosterone prescribing beyond federal DEA requirements. There is no mandatory specialist referral, no state-mandated waiting period, and no limitation on the number of refills (up to five refills within six months per DEA rules for Schedule III substances).
Patients transferring prescriptions from out-of-state pharmacies can do so within Iowa, but the receiving pharmacist must verify the prescription with the originating pharmacy and confirm the prescriber's license status. Controlled substance prescriptions cannot be transferred more than once.
For men filling testosterone cypionate at Iowa VA medical centers (Des Moines VA, Iowa City VA), the VA formulary covers testosterone cypionate with no copay for service-connected conditions and a $5 to $11 copay tier for non-service-connected prescriptions 11.
Frequently asked questions
›How much does Testosterone Cypionate cost in Iowa?
›Does Iowa Medicaid cover Testosterone Cypionate?
›Is compounded testosterone cypionate legal in Iowa?
›Can I get Testosterone Cypionate via telehealth in Iowa?
›Which insurance plans cover Testosterone Cypionate in Iowa?
›What's the cheapest way to get Testosterone Cypionate in Iowa?
›Are there Iowa Testosterone Cypionate discount programs?
›How does a generic savings card work in Iowa?
›Do I need to see a specialist to get TRT in Iowa?
›How often do I need lab work while on testosterone cypionate in Iowa?
›Can I transfer my testosterone prescription to an Iowa pharmacy?
›Is subcutaneous testosterone injection available in Iowa?
References
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- U.S. Food and Drug Administration. Depo-Testosterone (testosterone cypionate) FDA label. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085635
- Unger CA. Hormone therapy for transgender patients. Transl Androl Urol. 2016;5(6):877-884. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182227/
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and answers. https://www.fda.gov/drugs/human-drug-compounding/mixing-matching-and-modifying-drugs-pharmacy-compounding
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- U.S. Food and Drug Administration. FDA drug safety communication: FDA cautions about using testosterone products for low testosterone due to aging. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due
- Kang DY, Li HJ. The cost-effectiveness of testosterone replacement therapy: A systematic review. J Urol. 2019;203(4):671-678. https://pubmed.ncbi.nlm.nih.gov/31647919/
- Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559. https://pubmed.ncbi.nlm.nih.gov/20525906/
- Al-Futaisi AM, Al-Zakwani IS, Almahrezi AM, Morris D. Subcutaneous administration of testosterone: A pilot study report. Sultan Qaboos Univ Med J. 2006;6(1):69-72. https://pubmed.ncbi.nlm.nih.gov/28379417/
- Jasuja GK, Bhasin S, Rose AJ. Patterns of testosterone prescription overuse. Curr Opin Endocrinol Diabetes Obes. 2017;24(6):240-245. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046386/